Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Natco Pharma L Natco Pharma Ltd. | BSE 898.00 -0.80 (-0.09%) | NSE 892.80 -4.95 (-0.55%) | Trade | Add

BSE Live

Dec 09, 16:01

898.00 -0.80 (-0.09%)

Volume

AVERAGE VOLUME

5-Day

193,826

10-Day

363,453

30-Day

163,108

71,313

Prev. Close

898.80
Open Price

891.20

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 09, 15:58

892.80 -4.95 (-0.55%)

Volume

AVERAGE VOLUME

5-Day

2,980,216

10-Day

4,769,740

30-Day

2,225,140

703,288

Prev. Close

897.75
Open Price

895.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
892.80 (25)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Natco Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	4,411.60	3,978.80	2,696.90	1,904.90	1,690.30
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	4,411.60	3,978.80	2,696.90	1,904.90	1,690.30
Total Operating Revenues	4,429.50	3,998.80	2,707.10	1,944.80	2,052.10
Other Income	354.50	128.10	104.60	99.00	103.60
Total Revenue	4,784.00	4,126.90	2,811.70	2,043.80	2,155.70
EXPENSES
Cost Of Materials Consumed	536.20	522.50	475.30	519.20	372.90
Purchase Of Stock-In Trade	166.10	151.40	175.70	58.50	186.60
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	-12.50	42.70	-23.70	-16.80	-48.10
Employee Benefit Expenses	594.50	525.00	486.70	444.80	414.90
Finance Costs	23.90	19.20	14.50	17.70	13.30
Depreciation And Amortisation Expenses	235.20	186.80	163.80	142.60	116.90
Other Expenses	949.20	1,005.80	657.50	675.60	519.60
Total Expenses	2,492.60	2,453.40	1,949.80	1,841.60	1,576.10
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	2,291.40	1,673.50	861.90	202.20	579.60
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	2,291.40	1,673.50	861.90	202.20	579.60
Tax Expenses-Continued Operations
Current Tax	437.60	316.50	162.70	47.80	147.80
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-29.60	-31.30	-16.10	-15.60	-10.60
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	408.00	285.20	146.60	32.20	137.20
Profit/Loss After Tax And Before ExtraOrdinary Items	1,883.40	1,388.30	715.30	170.00	442.40
Profit/Loss From Continuing Operations	1,883.40	1,388.30	715.30	170.00	442.40
Profit/Loss For The Period	1,883.40	1,388.30	715.30	170.00	442.40
Minority Interest	2.00	0.00	0.00	0.00	-1.50
Consolidated Profit/Loss After MI And Associates	1,885.40	1,388.30	715.30	170.00	440.90
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	105.00	77.00	39.00	9.00	24.00
Diluted EPS (Rs.)	105.00	77.00	39.00	9.00	24.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	107.50	170.20	100.40	82.10	113.80
Tax On Dividend	0.00	0.00	0.00	0.00	0.00